Canon Unveils Ultimion PCCT Photon-Counting CT System

Canon Medical Systems USA announced its next-generation photon-counting CT system, which is pending 510(k) clearance.

Updated on Nov. 20, 2026 in Healthcare

Canon Unveils Ultimion PCCT Photon-Counting CT System

Canon Medical Systems USA, Inc. announced Ultimion PCCT, its next-generation photon-counting CT system, from Cleveland, Ohio. The system combines photon-counting detector technology with advanced image reconstruction and workflow innovations, and it is pending 510(k) clearance.

Why it matters

Ultimion is designed to support low-dose imaging, diagnostic confidence, and workflow productivity for clinical CT imaging. Canon is also bringing AI-enabled reconstruction to conventional CT, extending selected photon-counting benefits to a wider range of hospitals.

Canon's PIQE comparison reports resolution at a 0.5 mm high-contrast object size under 13 mGy SSDE dose across a 320 mm field of view. The announcement does not disclose pricing, unit shipments, or expected installed-base figures for Ultimion.

The players

Canon Medical Systems USA, Inc.

The U.S. subsidiary of Japanese medical imaging manufacturer Canon, responsible for marketing and distributing its CT, MRI, and ultrasound systems across the United States.

The details

Ultimion enables Always ON ultra-high-resolution and spectral imaging in a single acquisition and incorporates INSTINX, a workflow solution for integrating photon-counting CT into clinical practice. The system supports high-speed data handling, AI-enabled image reconstruction, air-cooled installation, and PACS integration, and was developed with Canon's global network of clinical collaborators.

Timeline

  1. - November 20, 2026: Canon announced Ultimion PCCT, with the announcement dated from Cleveland, Ohio.

Roadmap

Photon-counting CT, commercially introduced by Siemens Healthineers with its NAEOTOM Alpha system, has been moving from research into hospitals, and Ultimion places Canon in that competitive segment. Canon's extension of AI-enabled reconstruction to conventional CT reflects an industry push to bring photon-counting-style image quality to a broader installed base.

If cleared, Ultimion could allow hospitals to acquire images at lower radiation doses while preserving diagnostic detail, which may matter for patients who need repeated CT scans. The system is not yet available for clinical use, and availability will depend on FDA 510(k) clearance and individual hospital purchasing decisions.

The takeaway

Hospitals evaluating CT upgrades should watch for FDA clearance of Ultimion and compare its dose and resolution claims against independent clinical evaluations. Early adopters will likely weigh workflow integration costs alongside imaging performance.

Further reading

For broader context on hospital equipment and imaging technology markets, explore the Healthcare section.

More information

Review the specifications and clinical details on the Canon Medical Systems USA product information page.

Source note: This article includes information reported by The Manila times.